mRNA Cancer Vaccines and Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4144535
- 108 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global mRNA Cancer Vaccines and Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global mRNA Cancer Vaccines and Therapeutics market segmented into
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Based on the end-use, the global mRNA Cancer Vaccines and Therapeutics market classified into
Infectious Disease
Cancer
Other
Based on geography, the global mRNA Cancer Vaccines and Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS INDUSTRY
2.1 Summary about mRNA Cancer Vaccines and Therapeutics Industry
2.2 mRNA Cancer Vaccines and Therapeutics Market Trends
2.2.1 mRNA Cancer Vaccines and Therapeutics Production & Consumption Trends
2.2.2 mRNA Cancer Vaccines and Therapeutics Demand Structure Trends
2.3 mRNA Cancer Vaccines and Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Adeno Carcinomas
4.2.2 Mucinous Carcinomas
4.2.3 Adenosquamous Carcinomas
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Infectious Disease
4.3.2 Cancer
4.3.3 Other
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Adeno Carcinomas
5.2.2 Mucinous Carcinomas
5.2.3 Adenosquamous Carcinomas
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Infectious Disease
5.3.2 Cancer
5.3.3 Other
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Adeno Carcinomas
6.2.2 Mucinous Carcinomas
6.2.3 Adenosquamous Carcinomas
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Infectious Disease
6.3.2 Cancer
6.3.3 Other
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Adeno Carcinomas
7.2.2 Mucinous Carcinomas
7.2.3 Adenosquamous Carcinomas
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Infectious Disease
7.3.2 Cancer
7.3.3 Other
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Adeno Carcinomas
8.2.2 Mucinous Carcinomas
8.2.3 Adenosquamous Carcinomas
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Infectious Disease
8.3.2 Cancer
8.3.3 Other
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Adeno Carcinomas
9.2.2 Mucinous Carcinomas
9.2.3 Adenosquamous Carcinomas
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Infectious Disease
9.3.2 Cancer
9.3.3 Other
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Moderna Therapeutics
10.1.2 CureVac
10.1.3 Translate Bio
10.1.4 BioNTech
10.1.5 Sangamo Therapeutics
10.1.6 Argos Therapeutics
10.1.7 In-Cell-Art
10.1.8 eTheRNA
10.1.9 Ethris
10.1.10 Tiba Biotechnology
10.2 mRNA Cancer Vaccines and Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Moderna Therapeutics
10.2.2 CureVac
10.2.3 Translate Bio
10.2.4 BioNTech
10.2.5 Sangamo Therapeutics
10.2.6 Argos Therapeutics
10.2.7 In-Cell-Art
10.2.8 eTheRNA
10.2.9 Ethris
10.2.10 Tiba Biotechnology
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table mRNA Cancer Vaccines and Therapeutics Product Type Overview
Table mRNA Cancer Vaccines and Therapeutics Product Type Market Share List
Table mRNA Cancer Vaccines and Therapeutics Product Type of Major Players
Table Brief Introduction of Moderna Therapeutics
Table Brief Introduction of CureVac
Table Brief Introduction of Translate Bio
Table Brief Introduction of BioNTech
Table Brief Introduction of Sangamo Therapeutics
Table Brief Introduction of Argos Therapeutics
Table Brief Introduction of In-Cell-Art
Table Brief Introduction of eTheRNA
Table Brief Introduction of Ethris
Table Brief Introduction of Tiba Biotechnology
Table Products & Services of Moderna Therapeutics
Table Products & Services of CureVac
Table Products & Services of Translate Bio
Table Products & Services of BioNTech
Table Products & Services of Sangamo Therapeutics
Table Products & Services of Argos Therapeutics
Table Products & Services of In-Cell-Art
Table Products & Services of eTheRNA
Table Products & Services of Ethris
Table Products & Services of Tiba Biotechnology
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global mRNA Cancer Vaccines and Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
Table Global mRNA Cancer Vaccines and Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global mRNA Cancer Vaccines and Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global mRNA Cancer Vaccines and Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
